No headlines found.
No press releases found.
No news found.
The fund’s investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average. The fund also dynamically sells call options covering between 35% and 75% of the value of the fund’s equity portfolio, with a long-run target of 55%, in seeking to enhance the portfolio's risk-adjusted returns.
Nuveen Dow 30Sm Dynamic Overwrite Common Shares Of Beneficial Interest trades on the NYSE stock market under the symbol DIAX.
As of December 19, 2025, DIAX stock price climbed to $15.04 with 65,083 million shares trading.
DIAX has a beta of 0.81, meaning it tends to be less sensitive to market movements. DIAX has a correlation of 0.81 to the broad based SPY ETF.
DIAX has a market cap of $546.96 million. This is considered a Small Cap stock.
In the last 3 years, DIAX traded as high as $15.93 and as low as $12.42.
DIAX has underperformed the market in the last year with a return of +10.9%, while SPY returned +18.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in DIAX shares. However, DIAX has outperformed the market in the last 3 month and 2 week periods, returning +5.2% and +0.8%, while SPY returned +2.8% and -0.5%, respectively. This indicates DIAX has been having a stronger performance recently.
DIAX support price is $14.82 and resistance is $15.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DIAX shares will trade within this expected range on the day.
